← Back to directory

Björn Wettermark

Researcher Next ID · RN-021238

Researcher · Medicine

Uppsala University

Uppsala, Lithuania

Not currently recruitingFunding unknown
Works count
359
Citation count
11,651
H-index
55
i10-index
162

Research interests

Medicine
Economics, Econometrics and Finance
Medication Adherence and Compliance
Health Systems, Economic Evaluations, Quality of Life
Pharmaceutical Economics and Policy
Pharmaceutical Practices and Patient Outcomes
Blood Pressure and Hypertension Studies

Publications

  • Introduction to drug utilization research

    · 2024 · 10.1002/9781119911685.ch1

  • Albuminuria Testing in Hypertension and Diabetes: An Individual-Participant Data Meta-Analysis in a Global Consortium

    Hypertension · 2021 · 10.1161/hypertensionaha.121.17323

  • Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets

    Frontiers in Public Health · 2018 · https://doi.org/10.3389/fpubh.2018.00328

  • Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease

    Gastroenterology · 2017 · 10.1053/j.gastro.2017.05.046

  • High adherence to the ‘Wise List’ treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines

    BMJ Open · 2017 · 10.1136/bmjopen-2016-014345

  • The First Decade with the Swedish Prescribed Drug Register – A Systematic Review of the Output in the Scientific Literature

    Basic & Clinical Pharmacology & Toxicology · 2016 · 10.1111/bcpt.12613

  • Prevalence and recognition of chronic kidney disease in Stockholm healthcare

    Nephrology Dialysis Transplantation · 2016 · 10.1093/ndt/gfw354

  • Introduction to drug utilization research

    · 2016 · 10.1002/9781118949740.ch1

  • Comparison of treatment persistence with different oral anticoagulants in patients with atrial fibrillation

    European Journal of Clinical Pharmacology · 2015 · 10.1007/s00228-015-1983-z

  • The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness

    Clinical Kidney Journal · 2015 · 10.1093/ckj/sfv117

  • Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications

    Frontiers in Pharmacology · 2014 · 10.3389/fphar.2014.00106

  • High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden – a challenge for public health

    BMC Public Health · 2013 · 10.1186/1471-2458-13-670

  • Validation of asthma and eczema in population‐based Swedish drug and patient registers

    Pharmacoepidemiology and Drug Safety · 2013 · 10.1002/pds.3465

  • The Epidemiology of Heart Failure, Based on Data for 2.1 Million Inhabitants in Sweden

    European Journal of Heart Failure · 2013 · 10.1093/eurjhf/hft064

  • Differences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in Sweden

    BMJ Open · 2013 · 10.1136/bmjopen-2012-002378

  • Most common diseases diagnosed in primary care in Stockholm, Sweden, in 2011

    Family Practice · 2013 · 10.1093/fampra/cmt033

  • The Nordic prescription databases as a resource for pharmacoepidemiological research—a literature review

    Pharmacoepidemiology and Drug Safety · 2013 · 10.1002/pds.3457

  • Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications

    Frontiers in Pharmacology · 2011 · 10.3389/fphar.2010.00141

  • The ‘Wise List’– A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm

    Basic & Clinical Pharmacology & Toxicology · 2011 · 10.1111/j.1742-7843.2011.00682.x

  • Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications

    Expert Review of Pharmacoeconomics & Outcomes Research · 2010 · 10.1586/erp.10.72

  • Soft regulations in pharmaceutical policy making

    Applied Health Economics and Health Policy · 2009 · 10.1007/bf03256147

  • Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance

    Expert Review of Pharmacoeconomics & Outcomes Research · 2009 · https://doi.org/10.1586/14737167.9.1.65

  • The Nordic Countries as a Cohort for Pharmacoepidemiological Research

    Basic & Clinical Pharmacology & Toxicology · 2009 · https://doi.org/10.1111/j.1742-7843.2009.00494.x

  • The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months

    Pharmacoepidemiology and Drug Safety · 2006 · https://doi.org/10.1002/pds.1294

  • Drug utilization 90% - a simple method for assessing the quality of drug prescribing

    European Journal of Clinical Pharmacology · 1998 · 10.1007/s002280050431

Current projects

    No projects listed.